NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled a lawsuit it filed against PreventionGenetics late last year claiming patent infringement.
The two parties have also reached a licensing agreement, and GTG's lawsuit will be dismissed as a result. Terms of the settlement were not disclosed.
GTG sued Marshfield, Wis.-based PreventionGenetics in November alleging it infringed US Patent No. 5,612,179, which covers GTG's non-DNA coding technology. The patent is at the center of numerous patent infringement lawsuits filed by the Australian firm.
Earlier this month, the US Patent and Trademark Office granted a request from Merial for a second ex parte re-examination of the patent. In December, GTG settled with Roche 454 Life Sciences over the '179 patent. The two also reached a licensing agreement.